Understanding the genetic factors affecting health outcomes in small preterm infants
The Genetic Basis of Morbidity and Mortality in Small for Gestational Age Preterm Infants
This study is looking at how certain genes might affect the health and survival of preterm babies who are smaller than expected for their age, to help us understand why they might face more health challenges.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10932254 on NIH RePORTER |
What this research studies
This research investigates the genetic factors that contribute to health issues and mortality in preterm infants who are small for their gestational age. The team will analyze the prevalence of genetic disorders in this vulnerable population and their impact on health outcomes. By identifying specific genetic variants associated with these conditions, the research aims to uncover new insights into the causes of morbidity and mortality in these infants. The approach includes examining both common and rare genetic disorders through comprehensive genetic analysis.
Who could benefit from this research
Good fit: Ideal candidates for this research are preterm infants born small for their gestational age, particularly those under 4 weeks old.
Not a fit: Patients who are not preterm or who are not classified as small for gestational age may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and management of health risks in small for gestational age preterm infants.
How similar studies have performed: Previous research has shown that genetic factors play a significant role in similar populations, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Hays, Thomas — Columbia University Health Sciences
- Study coordinator: Hays, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.